Macro & Micro-bvunzo Sars-Cov-2 Respiratory Multiple Coince Solution Solution

Multiple Respatoratory Virus kutyisidzira munguva yechando

Matanho ekudzikisa kutapurirana kweSers-COV-2 zvave zvakabudirira mukudzora kutapurirana kwedzimwe nzira dzekufema dzekufema. Nyika dzakawanda sei dzinoderedza mashandisiro ematanho akadai, anochengetedza-cov-2 achatenderera nezvimwewo hutachiona hwekufema, achiwedzera mukana wekutapukira.

Nyanzvi dzinofungidzira kuti panogona kunge paine dambudziko rirwo rwechikuru munguva ino yechando nekuda kwemasanganiswa emwaka wefuma yekufutisa (funcaratory syndrome hutachiona Nhamba yezviitiko zvefudzi uye RSV gore rino ratove rakakwira kupfuura iro renguva imwechete mumakore apfuura. Varians itsva ba.4 uye ba.5 yeVarengi-Cov-2 virus vakakurira denderedzwa zvakare.

Pa "World Fl zuva 2022 Symposum" musi waNovember 1, 2022, Zhong Nansishan"Nyika ichiri kutarisana nenjodzi yedenderedzwa repamusoro revaSuper-Cov-2 Virus Denda uye nePeturuza Apidemic." Akaratidza kuti, "kunyanya nguva ino yechando, ichiri kufanira kusimbisa kutsvagisisa nyaya dzesainzi dzefuma uye kutonga."Maererano nehuwandu hweUS CDC, huwandu hwekushanya kwechipatara kwehutachiona hwekufema muUnited States kwakawedzera zvakanyanya nekuda kwekubatanidzwa kwefuma uye hutachiona hwehutsva.

Kuwedzera kweRsv maonero uye RSV-yakabatana emergency yedhipatimendi uye kupata muchipatara munzvimbo dzakawanda dzeUS, nematunhu ari pedyo nemwaka mwaka wepamusoro. Parizvino, nhamba yeRSV yeRSV nyaya matiri yasvika pakakwirira kwazvo mumakore makumi maviri nemashanu, zvichikonzera zvipatara zvevana kuti zviremerwa, uye zvimwe zvikoro zvakavharwa.

Iyo Featenza Apidemic yakatanga muAustralia muna Kubvumbi gore rino uye yakagara kwemwedzi mina. Kubva yaSeptember 25, pakanga paine zviitiko makumi maviri nezvishanu zvemazana maviri nemakumi maviri nenomwe nemazana mashanu emarabhareti efuruwenza, zvichikonzera kufa kwemakumi matatu. Kusiyana neizvi, pasi peVaridzi veCour-2 Vir tripment Direction Condition Consures, pachave neanenge zviuru makumi maviri nezvitanhatu muAustralia muna 2020 uye vashoma pane 1,000 muna 2021.

Iyo yechi30 Chivabvu Chirevo China China Kubva pakati paJune, nhamba yefuma-seyakafanana nemakesi yakataurwa muGuangzhou yakawedzera ne1.38 nguva ichienzaniswa negore rapfuura.

Migumisiro yemuenzaniso wezvegumi nenomwe yakaburitswa nehutano hwepasi rese muna Gumiguru zvakaratidza kuti kuwanda kwehuwandu hwehuwandu hwehuwandu hwehuwandu hwehuwandu hwekufutisa hwakawedzera kusvika makumi matanhatu muzana vachienzaniswa nedenda risati rasvika. Izvo zvakafanotaurawo kuti Peak inogumisa mwaka we20022 uchawedzera ne1--5 nguva, uye hosha inowedzera kusvika ku1 1-4.

2126 vanhu vakuru nevakuru-2 utachiona hwakabvumwa kuchipatara. Miedzo yeVirichorator Veral Co-hutachiona hwakanyorwa nevarwere mazana matanhatu nemakumi mapfumbamwe nemashanu nevarwere nevaridzi-cov-2. Virayeni yekutambudzika yakaonekwa muna 583 (8%% Varwere: Varwere vane mavairasi, varwere 220 vaive nehutachiona hwekutumirana, uye vatiririvha 136 vaive neanoda.

Co-Utachiona neVirwive Vhumi Vaibatanidzwa nekuwedzera kusawirirana kwekugamuchira Incanive Mirayation Miralation Kuenzaniswa neMuchalation Kuenzanisa neSurs-COV-2 Mono-Utachiona. Vari-COV-2 COVICES NEVHAMURAL TWVIRAS NEVEPULSKO uye Adenviruses yaive imwe neimwe yakabatana zvakanyanya nekuwedzera kusagadzikana kwerufu. Iyo kana yeiyo Insasive Mechancal Ventilation mufuteni Co-utachiona yaive 4.14 (9% CI 2.00-8.49, p = 0.0001). Iyo kana yeiyo-muchipatara modernity mufuturu dzevarwere veCollenza yaive 2.35 (95% CI 1.07-5.12, P = 0.031). Iyo kana yeiyo-muchipatara modernity muAdenovirus co-isina varwere vaive 1.6 (95% CI 1.03-2.44, P = 0.033).

Mhedzisiro yeichi chidzidzo chinotiudza zvakajeka kuti co-turs neyekuchinja-COV-2 hutachiona uye furuvini hutachiona imamiriro ezvinhu ane ngozi.

Pamberi pekutungira kweanopfupi-cov-2, zviratidzo zvehutachiona hwakasiyana hwekufema zvakafanana chaizvo, asi nzira dzekurapa dzakange dzakasiyana. Kana varwere vasingadziviriri bvunzo dzakawanda, kurapwa kwezviitiko zvekufema zvichawedzera kuomarara, uye kuchatambisa zviri nyore zviratiridzi panguva yakakwirira. Naizvozvo, dzakawanda bvunzo dzekubatana dzinotora basa rakakosha mukuongororwa kwekiriniki, uye vanachiremba vanokwanisa kupa mutsauko wezvevaridzi mumarwere ane varwere vane mweya wekufema kuburikidza neyakafeva swab sampuli.

Macro & Micro-bvunzo Sars-Cov-2 Respiratory Multiple Coince Solution Solution

Macro & micro-bvunzo ine technical mapuratifomu akadai seye fluorescent huwandu pccr, isothermal ipo, uye inopa dzakasiyana-siyana dzezvakawanda-2 previratory zvigadzirwa zvekuona. Zvese zvigadzirwa zvakawana EU CE Certification, neakanakisa chigadzirwa chiitiko uye zvakanaka mushandisi ruzivo.

1. Chaizvoizvo nguva fluorescent rt-pcr kit yekuona marudzi matanhatu ematanho ekufema

Kutonga kwemukati: Nyora zvizere maitiro ekuedza kuti uve nechokwadi chekuedza.
Kunyatsoita.
Kukwikwidza kwakanyanya: 300 makopi / ml yemari-cov-2, 500copies / ml yekufudza hutachiona, ML yeViripo (ml yeM9 yeMyColasma pneumoniae ,, 500copie / ml yeAdenicovirus.

2.

Kutonga kwemukati: Nyora zvizere maitiro ekuedza kuti uve nechokwadi chekuedza.

Kunyatsoita.

Kukwikwidza kwakanyanya: 300 makopi / ml of sars-cov-2,500copies / ml ye lfv a uye 500copies / ml ye lfv b.

3..

Nyore kushandisa

Imba yekudziya yekufambisa & kuchengetwa pa4-30 ° ℃

Kukwikwidza kwakanyanya & kujeka

Chigadzirwa Zita	Kutaurwa
Chaiyo nguva fluorescent rt-pccr kt yekutsvaga marudzi matanhatu ematanho ekufema	20 bvunzo / kit,48 bvunzo / kit,50 bvunzo / kit
Sars-cov-2 / furuwenza a / furuwenza b nucleic acid yakasanganiswa kit (fluorescence pcr)	48 bvunzo / kit,50 bvunzo / kit
Sars-cov-2, furuwenza a uye funyenza b antigen yekuona kit (immunochromatography)	1 bvunzo / kit,20 bvunzo / kit